|
Market Closed -
Toronto S.E.
15:35:00 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 32.42 CAD | +6.36% |
|
+7.92% | +30.52% |
| 10-15 | Goldman Sachs Adjusts Price Target on Amgen to $481 From $475 | MT |
| 10-13 | Goldman Sachs Adjusts Price Target on Amgen to $475 From $450 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,077B | |||||
| 612B | |||||
| 501B | |||||
| 364B | |||||
| 353B |
- Stock Market
- Stocks
- AMGN Stock
- AMGN Stock
- Charts Amgen Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
